Drawing for QS PHARMA

USPTO serial 76454803

QS PHARMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HICKEY,TONI
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with QS PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Denise I. Mroz

DENISE I MROZ WOODCOCK WASHBURN LLPONE LIBERTY PL 46TH FLPHILADELPHIA, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, mitigation, and treatment of cancer, cardiovascular diseases, central nervous system diseases, gastrointestinal diseases, infections, metabolic diseases, musculoskeletal diseases, obesity, respiratory diseases, thromboembolic diseases, and urogenital diseasesABANDONED—
035providing outsourcing services for pharmaceutical and other companies relating to the development of compounds and determining the viability and usefulness of compounds for medical and other applicationsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 29, 2004ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jun 29, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jun 29, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jun 18, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jun 18, 2004OP.TOPPOSITION TERMINATED NO. 999999—
Jun 18, 2004OP.DOPPOSITION DISMISSED NO. 999999—
Jun 2, 2004MAILPAPER RECEIVED—
Mar 23, 2004OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 13, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 18, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2003NPUBNOTICE OF PUBLICATION—
Sep 10, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2003CFITCASE FILE IN TICRS—
Aug 11, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2003MAILPAPER RECEIVED—
Feb 10, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance